Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Wenpeng Cao

Matched on ORCID iD 0000-0002-7345-755X; OpenAlex author ID A5075563091. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 5 papers · 2022: 4 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 4 papers

Papers 17

  1. Correction: Genome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alte… Co-author DOI 10.1007/s00535-026-02521-2↗
  2. Correction: Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. Co-author DOI 10.1038/s41420-025-02871-5↗
  3. Hypoxia-induced exosomal circ_0006840 promotes pancreatic cancer progress by regulating the WIF1 decay. Co-author DOI 10.1186/s12915-025-02320-w↗
  4. Targeted inhibition of OTUD7B enhances therapeutic sensitivity in KRAS- mutant pancreatic ductal adenocarcinoma by promoting ubiquitination of DHODH Co-author DOI 10.21203/rs.3.rs-11197976/v1↗
  5. aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative spl… Co-author DOI 10.1007/s00535-025-02272-6↗
  6. Genome-scale activation screen reveals lncRNA HNF1A-AS1 as a novel therapeutic target for pancreatic cancer metastasis Co-author DOI 10.21203/rs.3.rs-5388928/v1↗
  7. Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2. Co-author DOI 10.1111/jcmm.17852↗
  8. 5'-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis. Co-author DOI 10.3390/biom13101513↗
  9. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Co-author DOI 10.1038/s41419-022-04677-0↗
  10. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. Co-author DOI 10.1038/s41420-022-01008-2↗
  11. Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2. Co-author DOI 10.1080/21655979.2022.2054205↗
  12. Transformer 2 alpha homolog is a downstream gene of hypoxia-inducible factor 1 subunit alpha and is involved in the progression of pancreatic cancer. Co-author DOI 10.1080/21655979.2022.2079243↗
  13. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway. Co-author DOI 10.18632/aging.202569↗
  14. Hypoxia-related gene FUT11 promoted pancreatic cancer progression via maintaining the stabilization of PDK1 Co-author DOI 10.21203/rs.3.rs-152464/v3↗
  15. Hypoxia-Related Gene FUT11 Promoted Pancreatic Cancer Progression Via Maintaining The Stabilization of PDK1 Co-author DOI 10.21203/rs.3.rs-153965/v1↗
  16. Hypoxia-Related Gene FUT11 Promotes Pancreatic Cancer Progression by Maintaining the Stability of PDK1. Co-author DOI 10.3389/fonc.2021.675991↗
  17. miRNA‑7515 suppresses pancreatic cancer cell proliferation, migration and invasion via downregulating IGF‑1 expression. Last author DOI 10.3892/or.2021.8151↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shan Lei · 17 shared papers, 2021–2026 · strength 3.65
  2. Zhirui Zeng · 16 shared papers, 2021–2026 · strength 3.29
  3. Zhiwei He · 5 shared papers, 2021–2022 · strength 0.82
  4. Zhangxia Ren · 2 shared papers, 2022–2026 · strength 0.48
  5. Tengxiang Chen · 2 shared papers, 2024–2025 · strength 0.45
  6. Zijiang Yu · 3 shared papers, 2021 · strength 0.39
  7. Zhiwei He · 1 shared paper, 2026 · strength 0.36
  8. Peng Chen · 1 shared paper, 2026 · strength 0.32
  9. Tengxiang Chen · 1 shared paper, 2026 · strength 0.29
  10. Lirui Tang · 1 shared paper, 2026 · strength 0.26
  11. Yiran Chen · 1 shared paper, 2026 · strength 0.26
  12. Kun Cai · 1 shared paper, 2022 · strength 0.19
  13. Xiaowu Li · 1 shared paper, 2022 · strength 0.19
  14. Jie Wang · 1 shared paper, 2022 · strength 0.16
  15. Peng Chen · 1 shared paper, 2022 · strength 0.16
  16. Wenfeng Yu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.